HI SB602

Pharmacists in Hawaii are authorized to order and perform specimen collection for diagnostic tests related to SARS-CoV-2, respiratory illnesses (influenza, streptococcal pharyngitis), liver function issues, and CLIA-waived tests, provided specimens are not collected by vaginal swab, venipuncture, or seminal fluid collection.

Pharmacists must obtain a permit from the state health department and complete appropriate training through programs approved by the Accreditation Council for Pharmacy Education (ACPE), ACPE-accredited colleges of pharmacy, state or local health departments, or the pharmacy board before ordering or collecting specimens for these tests.

The definition of "practice of pharmacy" is expanded to explicitly include ordering and specimen collection for the specified diagnostic and CLIA-waived tests as part of pharmacists' scope of practice.

"CLIA-waived tests" are defined as any test classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. 263a).

The bill takes effect on December 31, 2050.